3-D Matrix Ltd (7777) - Financial and Strategic SWOT Analysis Review

  • ID: 4408877
  • SWOT Analysis
  • 34 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Aushon BioSystems Inc
  • Capital Genomix, Inc
  • CellSeed Inc
  • Kaketsuken
  • PharmaDesign Inc
  • MORE
3-D Matrix Ltd (7777) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applications in the field of surgical and medical regenerative medicine, cell therapy and drug discovery. 3-D Matrix's lead product, PuraMatrix caters to periodontal bone regeneration. The company has several collaborative agreements with academic research institutions, enterprises and medical institutions. The company operates through locations in the US, France, the Netherlands, China and Singapore. 3-D Matrix is headquartered in Chiyoda-ku, Tokyo, Japan.

3-D Matrix Ltd Key Recent Developments

Apr 05,2016: Patent Granted for “Cardiac Tissue Regeneration” with Self-Assembling Peptide Technology in Japan
Feb 15,2016: 3-D Matrix: Announcement of Change of Representative Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aushon BioSystems Inc
  • Capital Genomix, Inc
  • CellSeed Inc
  • Kaketsuken
  • PharmaDesign Inc
  • MORE
Section 1 - About the Company
  • 3-D Matrix Ltd - Key Facts
  • 3-D Matrix Ltd - Key Employees
  • 3-D Matrix Ltd - Major Products and Services
  • 3-D Matrix Ltd - History
  • 3-D Matrix Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • 3-D Matrix Ltd - Business Description
  • 3-D Matrix Ltd - Corporate Strategy
  • 3-D Matrix Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • 3-D Matrix Ltd - Strengths
  • 3-D Matrix Ltd - Weaknesses
  • 3-D Matrix Ltd - Opportunities
  • 3-D Matrix Ltd - Threats
  • 3-D Matrix Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • 3-D Matrix Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • 3-D Matrix Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • 3-D Matrix Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 05, 2016: Patent Granted for “Cardiac Tissue Regeneration” with Self-Assembling Peptide Technology in Japan
  • Feb 15, 2016: 3-D Matrix: Announcement of Change of Representative Directors
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • 3-D Matrix Ltd, Key Facts
  • 3-D Matrix Ltd, Key Employees
  • 3-D Matrix Ltd, Major Products and Services
  • 3-D Matrix Ltd, History
  • 3-D Matrix Ltd, Subsidiaries
  • 3-D Matrix Ltd, Key Competitors
  • 3-D Matrix Ltd, Ratios based on current share price
  • 3-D Matrix Ltd, Annual Ratios
  • 3-D Matrix Ltd, Annual Ratios (Cont...1)
  • 3-D Matrix Ltd, Annual Ratios (Cont...2)
  • 3-D Matrix Ltd, Interim Ratios
  • 3-D Matrix Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • 3-D Matrix Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • 3-D Matrix Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • 3-D Matrix Ltd, Performance Chart (2013 - 2017)
  • 3-D Matrix Ltd, Ratio Charts
  • 3-D Matrix Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • 3-D Matrix Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • PharmaDesign Inc
  • Kaketsuken
  • CellSeed Inc
  • Capital Genomix, Inc
  • Aushon BioSystems Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll